Clinical Trials Browser

Phase NA × Nivolumab × Head & Neck × Clear all

NCT04603248 2026-02-12

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Phase NA Active not recruiting

Squamous Cell Carcinoma of Head and Neck